236 results
Page 4 of 12
424B5
t92s157526u jdct
18 Jul 16
Prospectus supplement for primary offering
12:00am
424B5
5iecm
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
urdmyd ca
30 Nov 15
Current report (foreign)
12:00am
424B5
y9brtt464h78j 8z29
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
r8k j6pebtiy
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.1
i0scvsna 9q9c6
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
k9rnyu
8 Jun 15
Business combination disclosure
12:00am
6-K
EX-99.1
mcyuss55
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
425
du4g49
21 Apr 15
Business combination disclosure
12:00am
425
kh1njpph6j 5ajvga5gx
21 Apr 15
Business combination disclosure
12:00am
425
09blnc2
21 Apr 15
Business combination disclosure
12:00am
6-K
tz36ql2ss6iuxd
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
op3rdtb0horkye0s
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
ltopoy24n8o4p liljz
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am
6-K
EX-99.1
ejyxbhz28bg9 ed44q
5 Feb 15
Teva Reports Fourth Quarter and Full Year 2014 Results
12:00am
6-K
EX-99.1
y93wbwe8m wdz
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
9l0wmojb8qe7
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
p0ashzi ehjtoio7c
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am